Arab & Middle East News
(ARABNEWSWIRE.COM, August 06, 2018 ) Mycoplasma testing market is valued at around USD 590.74 million in 2018 and is anticipated to be growing at a CAGR of 12.7%, to attain USD 1074.03 million by the end of 2023. Mycoplasma is a genus of microorganism that lacks a cellular wall around their cellular membrane. Without a cell wall, they may be unaffected by many common antibiotics inclusive of penicillin or extraordinary beta-lactam antibiotics that focus on cell wall synthesis. They may be parasitic or saprotrophic.
Request Report Sample: https://www.marketdataforecast.com/market-reports/mycoplasma-testing-market-3662/request-sample
Increase in demand for Mycoplasma testing products is major driver of the market
Factors affecting market growth:
Speedy growth in the pharmaceutical and biotechnology industries (+)
Increase in demand for Mycoplasma testing products (+)
Researchers focusing on drug discovery and improvement (+)
Increasing R&D investments and government assistance (+)
Rising healthcare expenditure(+)
Stringent authorities’ policies (-)
High costs of Mycoplasma testing (-)
Get your customized report: https://www.marketdataforecast.com/market-reports/mycoplasma-testing-market-3662/customize-report
North America is dominating the overall global market in terms of revenue
The Global Mycoplasma testing market is geographically segmented into
Middle East and Africa
North America dominates the Mycoplasma testing market, with Europe trailing closely behind. Asia-Pacific region is projected to have the quickest growth rate due to the massive possibilities available in international locations like China, India, and Japan.
Browse full Table of Contents: https://www.marketdataforecast.com/market-reports/mycoplasma-testing-market-3662/
The leading companies of the market include Thermo Fisher Scientific Inc., Minerva Biolabs GmbH, Charles River Laboratories International, Inc., Gibraltar Laboratories, Sartorius AG, Lonza Group Ltd., Merck KGaA, Roche Diagnostics, SGS S.A., American Type Culture Collection, InvivoGen, PromoCell GmbH, Biological Industries Israel Beit Haemek Ltd., and WuXi AppTec.
Market Data Forecast.